The People of OyaGen
Grushenka H. I. Wolfgang, Ph.D., D.A.B.T.
Dr. Wolfgang is an independent pharmacology and toxicology consultant, assisting companies with their drug development programs. Dr. Wolfgang received a M.S. in Pharmacology and Toxicology at Duquesne University and a Ph.D. in Pharmacology and Toxicology from the University of Arizona. She became a Diplomate of the American Board of Toxicology in 1992. Dr. Wolfgang began her career as a post-doc at The Upjohn Company, and then held positions of increasing responsibility at Parke-Davis Pharmaceutical Research, Chiron Corporation, DDPlatform, Eos Biotechnology and Gilead Sciences. As Vice President of Drug Safety Evaluation at Gilead Sciences Dr. Wolfgang was responsible for the nonclinical development of early and late stage antiviral compounds (including filings for Truvada®, Atripla®, Complera® and Stribild®) and supported regulatory filings worldwide. Her experience includes preparation of 30+ INDs and 6 original NDAs along with supplemental NDAs and MAAs. Her expertise is in setting strategy for nonclinical programs, preparing for critical phase meetings with regulatory agencies, overseeing preparation of nonclinical documentation, and writing CTD sections to support filings.